Citations

Bacterial Toxin Research Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4945 total record number 317 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 13 out of 34
336 citations found

Inhibition of Dpp8/9 Activates the Nlrp1b Inflammasome

Okondo, M;Rao, S;Taabazuing, C;Chui, A;Poplawski, S;Johnson, D;Bachovchin, D;

Product: Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Validated MALDI-TOF-MS method for anthrax lethal factor provides early diagnosis and evaluation of therapeutics

Gallegos-Candela, M;Boyer, AE;Woolfitt, AR;Brumlow, J;Lins, RC;Quinn, CP;Hoffmaster, AR;Meister, G;Barr, JR;

Product: Anthrax Lethal Factor (LF), Recombinant from B. anthracis

  • Chemicals, reagents, equipment and safety:

    Recombinant LF (rLF) was purchased from List Biological Laboratories (Campbell, CA).

    Sample preparation:

    The MS method for anthrax LF relies on three simple steps that each add a layer of sensitivity and specificity (Fig. 1). LF-MABs selectively purify and concentrate total-LF (LF + LTx) (Step 1). Immobilized LF is reacted with an optimized peptide substrate which it hydrolyzes producing two unique LF-specific product peptides (Step 2). Because each LF molecule can continuously hydrolyze peptide substrate, this step allows amplification of the resulting signal and improves detection. Analysis of the cleaved peptides by high-sensitivity/high-resolution isotope-dilution (ID) MALDI-TOF MS (Step 3). This strategy has been successfully applied to several enzymatic protein toxins [22].

    Author did not indicate which specific lethal factor was utilized.  List Labs provides Product #172 (Anthrax Lethal Factor (LF), Recombinant from B. anthracis) and Product #169 (Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence).

Validation of an Anti-Protective Antigen ELISA for Quantitative IgG Evaluation in B. anthracis Immunized Horses

M, C;T, H;KV, B;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

  • Antigens:

    Recombinant protective antigen (rPA) was obtained from List Biological Laboratories (Campbell, CA). Each vial was reconstituted  

    Quantification of anti-PA IgG antibodies:

    Wells of an Immulon 2 HB, 96-well round bottom microtiter plate (Southern Biological, Birmingham, AL) were coated with 100 l of a coating solution (rPA diluted at 1 g/ml in a 0.01 M PBS solution, pH 7.4). …

    Titration Curve:

    Eight rPA-coated microtiter plates were prepared. Following overnight incubation, approximately 200 l of REF plasma that had been diluted to 1:500 was added to the first well of three rows on each plate then two-fold serial dilutions carried out. …

    Specificity:

    In the second experiment, two rPA coated microtiter plates were prepared, except that ovalbumin (100 l diluted at 1 g/ml in a 0.01 M PBS solution), a heterologous protein to B. anthracis PA, was also used to coat six wells in each plate. …

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling

Seshadri, S;Allan, DSJ;Carlyle, JR;Zenewicz, LA;

Product: Anthrax Lethal Factor (LF), Recombinant, Mutant E687C from B. anthracis

  • Lethal toxin and signaling inhibitors:

    Recombinant protective antigen and wild-type lethal factor or lethal factor mutant (E687C) were obtained from List Biologicals (Campbell, CA) …

    In vitro lethal toxin assay with Rag1-/- splenocytes or human tonsillar lymphocytes:

    100,000500,000 splenocytes per well were incubated in a round bottom 96 well plate in IMDM media supplemented with 10% FBS, 100 U/ml pencillin, 100 U/ml streptomycin, IL-2 (20 ng/ml) and IL-7 (10 ng/ml). Human tonsillar lymphocytes (2×106) were plated in 200 l RPMI media supplemented with 10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, non-essential amino acids, sodium pyruvate, IL-2 (20 ng/ml), IL-7 (10 ng/ml) and IL-1 (20 ng/ml). For initial lethal toxin experiments splenocytes/tonsillar lymphocytes were cultured in media containing in 0.1% serum to minimize the effect of serum on lethal factor enzyme activity. After the initial period of lethal toxin treatment (3 hrs), serum was replenished to a full concentration of 10%. Cells after toxin treatment were stimulated with recombinant mouse or human IL-23 (50 ng/ml) (eBioscience) for 18 hrs. Cell supernatants were harvested by centrifugation at 1,500 rpm for 5 minutes and then used for the measurement of IL-22.

    In vitro lethal toxin assay with MNK-3 cells:

    MNK-3 cells (an ILC3 cell line) were cultured in MNK-3 media (DMEM (High glucose), 10% FBS, 100 U/ml penicillin, 100 U/ml streptomycin, 2 mM Glutagro, 1 mM sodium pyruvate, 10 mM HEPES, 55 M -mercaptoethanol, 5 g/ml gentamicin, 10 ng/ml IL-7 and 10 ng/ml IL-15). For lethal toxin experiments MNK-3 cells were cultured in media containing 10 ng/ml IL-7. Cells were treated with lethal toxin for 2 hrs followed by IL-23 stimulation for 6 hrs. Cell lysates were analyzed for RNA and supernatants were analyzed for secreted IL-22 by ELISA.

    Lethal Toxin (LT) = PA + LF

    Product #171E – Anthrax Protective Antigen (PA), Recombinant from B. anthracis

    Author did not specify which Lethal Factor (LF) was utilized; List Labs provides the following LF:

    Prodcut #172 – Anthrax Lethal Factor (LF), Recombinant from B. anthracis
    Product #169L – Anthrax Lethal Factor (LF-A), Recombinant from B. anthracis Native Sequence

Effect of endosomal acidification on small ion transport through the anthrax toxin PA63 channel

Kalu, N;Alcaraz, A;Yamini, G;Momben Abolfath, S;Lucas, L;Kenney, C;Aguilella, VM;Nestorovich, EM;

Product: Anthrax Protective Antigen, Activated (PA 63) from B. anthracis

Anthrax lethal toxin rapidly reduces c-Jun levels by inhibiting c-Jun gene transcription and promoting c-Jun protein degradation

Ouyang, W;Guo, P;Fang, H;Frucht, DM;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

Use of the mice passive protection test to evaluate the humoral response in goats vaccinated with Sterne 34F2 live spore vaccine

Phaswana, PH;Ndumnego, OC;Koehler, SM;Beyer, W;Crafford, JE;van Heerden, H;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis